Sitara Peroxide Statistics
Total Valuation
Sitara Peroxide has a market cap or net worth of PKR 731.73 million. The enterprise value is 1.38 billion.
Market Cap | 731.73M |
Enterprise Value | 1.38B |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sitara Peroxide has 55.10 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 55.10M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.89 |
PB Ratio | 0.55 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.74 |
EV / Sales | 1.67 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.77 |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.50.
Current Ratio | 0.47 |
Quick Ratio | 0.18 |
Debt / Equity | 0.50 |
Debt / EBITDA | n/a |
Debt / FCF | -3.22 |
Interest Coverage | -11.03 |
Financial Efficiency
Return on equity (ROE) is -45.87% and return on invested capital (ROIC) is -18.98%.
Return on Equity (ROE) | -45.87% |
Return on Assets (ROA) | -11.68% |
Return on Capital (ROIC) | -18.98% |
Revenue Per Employee | 3.15M |
Profits Per Employee | -3.03M |
Employee Count | 292 |
Asset Turnover | 0.22 |
Inventory Turnover | 3.00 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.71% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -23.71% |
50-Day Moving Average | 13.46 |
200-Day Moving Average | 13.45 |
Relative Strength Index (RSI) | 50.08 |
Average Volume (20 Days) | 37,193 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sitara Peroxide had revenue of PKR 824.00 million and -792.78 million in losses. Loss per share was -14.39.
Revenue | 824.00M |
Gross Profit | -273.39M |
Operating Income | -686.04M |
Pretax Income | -753.26M |
Net Income | -792.78M |
EBITDA | -498.22M |
EBIT | -686.04M |
Loss Per Share | -14.39 |
Balance Sheet
The company has 9.14 million in cash and 653.96 million in debt, giving a net cash position of -644.83 million or -11.70 per share.
Cash & Cash Equivalents | 9.14M |
Total Debt | 653.96M |
Net Cash | -644.83M |
Net Cash Per Share | -11.70 |
Equity (Book Value) | 1.32B |
Book Value Per Share | 23.97 |
Working Capital | -792.79M |
Cash Flow
In the last 12 months, operating cash flow was -194.84 million and capital expenditures -8.56 million, giving a free cash flow of -203.39 million.
Operating Cash Flow | -194.84M |
Capital Expenditures | -8.56M |
Free Cash Flow | -203.39M |
FCF Per Share | -3.69 |
Margins
Gross margin is -33.18%, with operating and profit margins of -83.26% and -96.21%.
Gross Margin | -33.18% |
Operating Margin | -83.26% |
Pretax Margin | -91.42% |
Profit Margin | -96.21% |
EBITDA Margin | -60.46% |
EBIT Margin | -83.26% |
FCF Margin | -24.68% |
Dividends & Yields
Sitara Peroxide does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 0.01% |
Earnings Yield | -108.34% |
FCF Yield | -27.80% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Sitara Peroxide has an Altman Z-Score of -0.71. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.71 |
Piotroski F-Score | n/a |